Want to join the conversation?
$LH said its LabCorp Diagnostics segment net revenue for 2Q16 was $1.66Bil, up 5.4% YoverY, helped by organic volume growth, price, mix and tuck-in acquisitions. For Covance Drug Development segment, net revenue rose 12.2% to $722.4MM, helped by broad-based demand, partially offset by the negative impact of foreign currency translation.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.